NCR2 and neoplasm: We previously reported the evolution of a NK cell subset expressing a specific splice variant of NKp44 (14, 44), and the microenvironment of placenta, as well as tumor, was enriched with TGF-β and other cytokines that can actively modulate NKp44 splice variant expression.